ADHD Drug Medication Guide On Potential Cardiac Risks Recommended By Committee

FDA’s Drug Safety & Risk Management Advisory Committee recommended that the agency issue a medication guide for attention deficit/hyperactivity disorder drugs on potential cardiovascular risks of the stimulant class; committee splits on “black box” warning for ADHD drugs.